Abstract: Please replace the original abstract paragraph with the following new paragraph. A mobile terminal includes a housing and a camera. The camera is rotatably coupled to the housing and configured for locking at a specified position. When the camera is locked at a first specified position, the camera is located inside the housing and one side of the camera is exposed outside the housing, and when the camera is locked at a second specified position, a lens of the camera is exposed outside the housing. The mobile terminal further includes a drive apparatus and a touch apparatus. The drive apparatus is configured to drive the camera to rotate, and the touch apparatus includes a touch sensor and a control chip. After receiving a touch signal from the touch sensor, the control chip controls the drive apparatus to drive the camera to rotate to the second specified position.

Abstract: The present disclosure provides an ultralow-glossiness, ultralow-temperature resistant ASA resin composition and preparation method thereof. The composition includes the following components in parts by weight: 20˜60 parts of an acrylonitrile-styrene-acrylate graft copolymer, 40˜80 parts of an acrylonitrile-styrene copolymer, 1˜20 parts of an ultralow-glossiness, low temperature resistant modifier, and 0.1˜5 parts of a processing aid. The ultralow-glossiness, low temperature resistant modifier includes a carrier copolymer, a fluorinated copolymer, a low-temperature flexibilizer, a coupling agent, fumed silica and an assistant.

Abstract: The present invention relates to dihydroquinoxaline bromodomain recognition protein inhibitor, preparation method and use thereof. The inhibitor of the present invention is compound represented by general formula (I), or stereoisomer, pharmaceutically acceptable salt, prodrug, solvate, hydrate and crystal form thereof. The definition of each substituent is as described in the description and claims. The compound represented by general formula (I) of the present invention may inhibit bromodomain recognition protein and may be used for preparing medicament which regulates the apparent state of cells and treats series of diseases and symptoms which are mediated by the bromodomain recognition protein.

Abstract: Provided in the present invention are a di-substituted maleic amide linker conjugated to an antibody and a preparation method and use thereof. In particular, the present invention conjugates a strongly cytotoxic active substance to a biomacromolecule through a class of new linkers. The class of linkers can selectively act simultaneously with disulphide chains, so as to greatly improve the substance homogeneity of a conjugate. The conjugate prepared by the linker of the present invention has a high inhibitory activity on a cell strain expressing the corresponding antigen. Also provided is a method for preparing the above-mentioned conjugate and the use.

Abstract: A method, a component, and an electronic device relating to the field of industrial automation technology, particularly relating to the creation of a human machine interface, and are used for automatically creating an HMI of a system. The method for creating an HMI comprises: a first component of a system receives, via an HMI, a first command for creating an HMI for the system; the first component obtains, from each searched and found second component of the system an HMI resource of each of the second components; and the first component creates, on the basis of an HMI resource of the first component and the obtained HMI resource from each of the second components, the HMI for the system. One component of the system collects the HMI resource of another component of the system and creates the HMI for the whole system, providing a method for automatically creating the HMI for the system.

Abstract: A tissue factor (TF)-targeted antibody-drug conjugate (ADC) and a method for preparing the ADC. The ADC is capable of binding to TF antigen with high specificity, and has high affinity, low immunogenicity, high cytotoxicity, and significant anti-tumor activity.

Abstract: Provided is a process of synthesizing a substituted pyridine and pyrimidine compound. Particularly, provided is a method for preparing a compound of formula III via a compound of formula II?, wherein the definition of each of groups is as described as the description. Compound with other methods, the method in the present invention has features of high yield and a result product being easier to separate.

Abstract: A method is for executing an application in a cloud system. The method includes receiving a request from a first user for executing an application in the cloud system; receiving, from the first user, user data of the first user related to the execution of the requested application; storing the received user data in a first storage area of a computing environment of the cloud system; in the computing environment, executing the requested application based on the stored user data of the first user to obtain an execution result; and storing the execution result in a second storage area of the computing environment, the access permission of the first user to the first storage area being a write-only permission, and the access permission of the first user to the second storage area being a read-only permission. As such, data privacy protection and security can be provided in the cloud system.

Abstract: A method is disclosed for notifying a patient before blood pressure monitoring. Also provided is a dynamic blood pressure monitor, which is used for notifying a patient before commencement of a blood pressure measurement.

Abstract: This invention provides a class of five-member-heterocycle fused pyridine compounds as shown below in Formula (X), pharmaceutically acceptable salts or pharmaceutically acceptable solvates thereof, a method of producing the same, pharmaceutical compositions containing the compound, and use of the compounds in preparing medicament for preventing and/or treating diseases and tumors associated with abnormal protein tyrosine kinase.

Abstract: A method, computer program product, and computer system for backfilling jobs based on energy aware scheduling are provided. A first job is received at a scheduler, where the scheduler manages one or more running jobs based on a plurality of system resources. The plurality of system resources comprises at least one resource constraint. A resource consumption of the first job is estimated based on one or more resource requirements of the first job. A first resource requirement of the one or more resource requirements is determined to exceed the resource constraint. In response to determining that the first resource requirement of the first job exceeds at least one resource constraint, at least one of (i) the first resource requirement of the first job and (ii) the plurality of system resources is modified. The first job is scheduled.

Abstract: Provided is a process of synthesizing a substituted pyridine and pyrimidine compound. Particularly, provided is a method for preparing a compound of formula III via a compound of formula II?, wherein the definition of each of groups is as described as the description. Compound with other methods, the method in the present invention has features of high yield and a result product being easier to separate.

Abstract: A production process monitoring system is used to monitor a set of production parameters in a production process of a plurality of production units that perform parallel production operation. The production units comprise at least one reference production unit and at least one distribution production unit. The reference production unit comprises a first sensor, a second sensor, and a reference control unit. The distribution production unit comprises a second sensor and a distribution controller. The first and second sensors of the reference production unit is configured to monitor a first and second parameters in the production parameters in the reference production unit and output a first and second signals corresponding to the first and second parameters. The second sensor of the distribution production unit is configured to monitor the second parameter in the distribution production unit and output a second parameter distribution signal corresponding to the second parameter.

Abstract: The present invention belongs to the field of pharmaceutical Chemistry. In particular, the present invention relates to a pyridopyrimidine or pyrimidopyrimidine compound as represented by general formula (I), or an isomer thereof or a pharmaceutically acceptable salt, ester, prodrug or solvate thereof, a preparation method, a pharmaceutical composition and uses thereof in preparing a mTOR inhibitor. As a mTOR inhibitor, the compound or the pharmaceutical composition thereof can be used for treating a disease or condition due to PI3K-AKT-mTOR signalling pathway malfunction.

Abstract: A method, computer program product, and computer system for backfilling jobs based on energy aware scheduling are provided. A first job is received at a scheduler, where the scheduler manages one or more running jobs based on a plurality of system resources. The plurality of system resources comprises at least one resource constraint. A resource consumption of the first job is estimated based on one or more resource requirements of the first job. A first resource requirement of the one or more resource requirements is determined to exceed the resource constraint. In response to determining that the first resource requirement of the first job exceeds at least one resource constraint, at least one of (i) the first resource requirement of the first job and (ii) the plurality of system resources is modified. The first job is scheduled.

Abstract: This invention provides a class of five-member-heterocycle fused pyridine compounds as shown below in Formula (X), pharmaceutically acceptable salts or pharmaceutically acceptable solvates thereof, a method of producing the same, pharmaceutical compositions containing the compound, and use of the compounds in preparing medicament for preventing and/or treating diseases and tumours associated with abnormal protein tyrosine kinase.

Abstract: The present invention belongs to the field of pharmaceutical Chemistry. In particular, the present invention relates to a pyridopyrimidine or pyrimidopyrimidine compound as represented by general formula (I), or an isomer thereof or a pharmaceutically acceptable salt, ester, prodrug or solvate thereof, a preparation method, a pharmaceutical composition and uses thereof in preparing a mTOR inhibitor. As a mTOR inhibitor, the compound or the pharmaceutical composition thereof can be used for treating a disease or condition due to PI3K-AKT-mTOR signalling pathway malfunction.

Abstract: A production process monitoring system is used to monitor a set of production parameters in a production process of a plurality of production units that perform parallel production operation. The production units comprise at least one reference production unit and at least one distribution production unit. The reference production unit comprises a first sensor, a second sensor, and a reference control unit. The distribution production unit comprises a second sensor and a distribution controller. The first and second sensors of the reference production unit is configured to monitor a first and second parameters in the production parameters in the reference production unit and output a first and second signals corresponding to the first and second parameters. The second sensor of the distribution production unit is configured to monitor the second parameter in the distribution production unit and output a second parameter distribution signal corresponding to the second parameter.

Abstract: This application discloses a novel process to synthesize 3-amino-4-substituted pyrazole derivatives, which may be used, for example, as intermediates to prepare compounds having, for example, pharmaceutical utility.

Abstract: This application discloses a novel process to synthesize 3-amino-4-substituted pyrazole derivatives, which may be used, for example, as intermediates to prepare compounds having, for example, pharmaceutical utility.